Home

Press Releases

12345678910
Endace Integrates with Microsoft Sentinel for Deep Network Visibility
Packet capture authority Endace today announced an integration between EndaceProbe and Microsoft Sentinel, a next-generation cloud security, information, and event management (SIEM) solution. The integration provides NetOps and SecOps teams with one-click access to definitive, full packet evidence from within Microsoft Sentinel to streamline investigations. Access to Endace’s Always-On packet capture enables accurate event reconstruction and helps security teams to investigate and respond to threats more quickly, with absolute confidence.
By Endace · Via Business Wire · April 21, 2025
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer
Positive high-level results from a planned interim analysis of the DESTINY-Breast09 Phase III trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to a taxane, trastuzumab and pertuzumab (THP) as a 1st-line treatment for patients with HER2-positive metastatic breast cancer.
By AstraZeneca · Via Business Wire · April 21, 2025
Redwire Expands In-Space Drug Development Program, Launches New PIL-BOX Technology and Cancer-Detection Experiment
Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next-generation space economy, announced today that it has launched a new drug development technology and a cancer-detection experiment to the International Space Station (ISS) as the company scales its in-space pharmaceutical drug development program based on the success of its PIL-BOX platform.
By Redwire Corporation · Via Business Wire · April 21, 2025
Phillips 66 Issues Letter to Shareholders
Phillips 66 (NYSE:PSX) today sent a letter to shareholders highlighting valuable information for shareholders to make an informed voting decision at Phillips 66’s upcoming Annual Meeting on May 21, 2025. The letter:
By Phillips 66 · Via Business Wire · April 21, 2025
4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings
4M Therapeutics Inc. (4MTx), an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the Company’s CEO, Pablo Lapuerta, M.D., will participate in panel discussions at the upcoming American Psychological Association (APA)’s Annual Meeting taking place on May 17-21, 2025, in Los Angeles, California, and the American Society of Clinical Psychopharmacology (ASCP)’s Annual Meeting taking place on May 27-30, 2025, in Scottsdale, Arizona.
By 4M Therapeutics Inc. · Via Business Wire · April 21, 2025
MSCI and Moody's to Launch Independent Risk Assessments for Private Credit Investments
MSCI Inc. (NYSE:MSCI) and Moody’s Corporation (NYSE:MCO) will jointly create a first-of-its-kind solution to provide independent risk assessments for private credit investments at scale.
By MSCI Inc. · Via Business Wire · April 21, 2025
Southeastern Grocers donates $107,750 to 8 leading children’s hospitals across the Southeast
Southeastern Grocers, LLC (SEG), parent company and home of Harveys Supermarket and Winn-Dixie, together with its generous customers, is donating $107,750 to eight leading children’s hospitals across the Southeast, demonstrating the grocer’s ongoing commitment to supporting local children and their families. As part of this initiative, SEG partnered with Roc Solid Foundation to create a customized backyard playset for one special oncology patient and her family, providing a safe, joyful space for play as she continues her recovery journey.
By Southeastern Grocers, LLC · Via Business Wire · April 21, 2025
Guaranty Bancshares, Inc. Reports First Quarter 2025 Financial Results
Guaranty Bancshares, Inc. (NYSE: GNTY) (the "Company," "we," "us," or "our"), the parent company of Guaranty Bank & Trust, N.A. (the "Bank"), today reported financial results for the fiscal quarter ended March 31, 2025. The Company's net income available to common shareholders was $8.6 million, or $0.76 per basic share, for the quarter ended March 31, 2025, compared to $10.0 million, or $0.88 per basic share, for the quarter ended December 31, 2024 and $6.7 million, or $0.58 per basic share, for the quarter ended March 31, 2024. Return on average assets and average equity for the first quarter of 2025 were 1.13% and 10.83%, respectively, compared to 1.27% and 12.68%, respectively, for the fourth quarter of 2024 and 0.85% and 8.93%, respectively, for the first quarter of 2024. The decrease in earnings during the first quarter of 2025 compared to the fourth quarter of 2024 was primarily due to higher noninterest expense and lower noninterest income. The increase in earnings in the first quarter of 2025 compared to the first quarter of 2024 was primarily due to an increase in net interest income in the current quarter compared to the prior year quarter.
By Guaranty Bancshares, Inc. · Via Business Wire · April 21, 2025
William T. Yardley Elected to the Board of Directors of New Jersey Resources
The board of directors of New Jersey Resources (NYSE: NJR) today announced the unanimous election of William T. Yardley to the board, effective July 1, 2025.
By New Jersey Resources · Via Business Wire · April 21, 2025
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American Thoracic Society (ATS) International Conference in San Francisco on May 16-21, 2025.
Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025
Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open.
By Pediatrix Medical Group, Inc. · Via Business Wire · April 21, 2025
USA Rare Earth Announces Date for First Quarter 2025 Results and Conference Call
STILLWATER, Okla., April 21, 2025 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced that it will release financial results for the quarterly period ended March 31, 2025, after U.S. markets close on Wednesday, May 14, 2025. Additionally, the Company will host a conference call that afternoon to discuss the results and related matters.
By USA Rare Earth, Inc. · Via GlobeNewswire · April 21, 2025
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
PRINCETON, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 1, 2025, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2025.
By Amicus Therapeutics, Inc. · Via GlobeNewswire · April 21, 2025
PX Energy, an Expanding Vertically Integrated Refinery and Mining Operation Located in Southern Brazil, Intends to Go Public Through a Business Combination with Papaya Growth Opportunity Corp. I, Including a Committed $10 Million Investment
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- PX Energy (“PX” or the “Company”), a vertically-integrated refined products manufacturer serving the Brazilian market for refined oil and agricultural grade products (through its parent company, Forbes & Manhattan Resources Inc.), and Papaya Growth Opportunity Corp. I (“PPYA”) announced today that they have entered into a definitive business combination agreement (the “BCA” and the transactions contemplated under the BCA, the “Business Combination” or the “Transaction”). Upon the completion of the Business Combination, the combined company will retain its name “PX Energy” and its headquarters in Brazil, and its ordinary shares to be listed on Nasdaq. PX Energy website is located at: https://pxenergy.com.br
By Forbes & Manhattan Inc. · Via GlobeNewswire · April 21, 2025
ENCORE ENERGY CORP. (NASDAQ: EU) DEADLINE ALERT: Bernstein Liebhard LLP Reminds enCore Energy Corp. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
PERPETUA RESOURCES CORP. (NASDAQ: PPTA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Perpetua Resources Corp. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
READY CAPITAL CORPORATION (NYSE: RC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ready Capital Corporation Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
ULTRA CLEAN HOLDINGS, INC. (NASDAQ: UCTT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ultra Clean Holdings, Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the first quarter 2025 performance and quarterly rebalancing of the OTCQX® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.
By OTC Markets · Via GlobeNewswire · April 21, 2025
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Enzo Biochem, Inc. (OTCQX: ENZB), life sciences company, has qualified to trade on the OTCQX® Best Market. Enzo Biochem, Inc. previously traded on the New York Stock Exchange.
By OTC Markets · Via GlobeNewswire · April 21, 2025
ROCKET LAB USA, INC. (NASDAQ: RKLB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rocket Lab USA, Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 29
ADDISON, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it will report its first quarter of 2025 financial results on April 29, 2025, premarket. The Company will also host its earnings call starting at 8:30 a.m. Eastern Time (7:30 a.m. CT). The Company’s financial results and presentation will be posted on its website at www.cecoenviro.com.
By CECO Environmental Corp. · Via GlobeNewswire · April 21, 2025
Apellis Announces Craig Wheeler to Join the Board of Directors
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective immediately. Mr. Wheeler is a highly accomplished executive with more than 30 years of leadership experience across the biopharmaceutical industry.
By Apellis Pharmaceuticals, Inc. · Via GlobeNewswire · April 21, 2025
OMNI-LITE INDUSTRIES REPORTS FOURTH QUARTER AND FISCAL 2024 RESULTS
CONFERENCE CALL FOR INVESTORS: APRIL 22, 2025, AT 4:00 PM EDT
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Viatris Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) --
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
BIGBEAR.AI HOLDINGS, INC. (NYSE: BBAI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds BigBear.ai Holdings, Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
SKYWORKS SOLUTIONS, INC. (NASDAQ: SWKS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Skyworks Solutions, Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
TFI INTERNATIONAL INC. (NYSE: TFII) DEADLINE ALERT: Bernstein Liebhard LLP Reminds TFI International Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) --  Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 5,000 ACUT shares in the open market. This brings his total holding to 4,915,759 shares.
By AccuStem Sciences, Inc. · Via GlobeNewswire · April 21, 2025
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) --  Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced next phase of growth including changes to its leadership team and the expanded development of IMVT-1402 into two new indications, SjD and CLE.
By Roivant Sciences · Via GlobeNewswire · April 21, 2025
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · April 21, 2025
Global Silicon Photonics and Photonic Integrated Circuits Market Report 2025-2035, with Comprehensive Profiles of 180+ Companies Across the Silicon Photonics and Photonic Integrated Circuits Ecosystem - ResearchAndMarkets.com
The "Global Silicon Photonics and Photonic Integrated Circuits Market 2025-2035" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · April 21, 2025
Rubic Management Launches All-in-One Business Automation Platform for Entrepreneurs
Systemize, automate, and scale — Rubic simplifies business growth for small business owners and solo entrepreneurs.
Mako Mining Announces Q1 2025 Production Results Generating Record Gold Revenue of US$31.5 million
VANCOUVER, BC / ACCESS Newswire / April 21, 2025 / Mako Mining Corp. (TSX-V:MKO)(OTCQX:MAKOF) ("Mako" or the "Company") is pleased to provide first quarter 2025 ("Q1 2025") production results for the Company's San Albino gold mine ("San Albino") in northern Nicaragua and an update on the Eagle Mountain gold project in Guyana. Certain amounts shown in this news release may not total to exact amounts due to rounding differences. All amounts expressed in U.S. dollars unless otherwise noted.
Via ACCESS Newswire · April 21, 2025
Bank of Hawai‘i Corporation First Quarter 2025 Financial Results
Bank of Hawai‘i Corporation (NYSE: BOH) (the “Company”) today reported diluted earnings per common share of $0.97 for the first quarter of 2025, compared with $0.85 during the linked quarter and $0.87 during the same period last year. Net income for the first quarter of 2025 was $44.0 million, up 12.3% from the linked quarter and up 20.9% from the same period last year. The return on average common equity for the first quarter of 2025 was 11.80% compared with 10.30% during the linked quarter and 11.20% during the same period last year.
By Bank of Hawai‘i Corporation · Via Business Wire · April 21, 2025
Innovative Industrial Properties Announces First Quarter 2025 Earnings Release Date and Conference Call
Innovative Industrial Properties, Inc. (IIP) (NYSE: IIPR) announced today it will report its first quarter 2025 results after the close of trading on the New York Stock Exchange on Wednesday, May 7, 2025.
Eaton to announce first quarter 2025 earnings on May 2, 2025
Intelligent power management company Eaton (NYSE:ETN) will announce first quarter 2025 earnings on Friday, May 2, 2025, before the opening of the New York Stock Exchange. The company will host a conference call at 11 a.m. Eastern time that day to discuss first quarter 2025 earnings results with securities analysts and institutional investors.
By Eaton · Via Business Wire · April 21, 2025
BJ’s Wholesale Club Announces First Quarter Fiscal 2025 Earnings Conference Call Date
BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ), a leading operator of membership warehouse clubs, today announced that it will release financial results for the first quarter fiscal 2025 prior to the market open on Thursday, May 22, 2025 and will hold a conference call on the same day at 8:30 a.m. ET to discuss its financial performance.
Blue Moon Metals Appoints Boi Linh Doig as Vice-President, Mining
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce the appointment of Boi Linh Doig as Vice-President, Mining, as it continues to build out its management team to support the Company's continued growth in the development of its three polymetallic brownfield projects.
By Blue Moon Metals Inc · Via GlobeNewswire · April 21, 2025
Global Self-Healing Materials Market Report 2025-2035, with Assessments of 35 Key Players Including Technology Portfolios, Commercialization Status and Strategic Direction - ResearchAndMarkets.com
The "Global Self-Healing Materials Market 2025-2035" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · April 21, 2025
QXO Extends Tender Offer to Acquire Beacon Roofing Supply
QXO, Inc. (NYSE: QXO) announced today that it is extending its all-cash tender offer to acquire all outstanding shares of Beacon Roofing Supply, Inc. (Nasdaq: BECN) for $124.35 per share.
By QXO, Inc · Via Business Wire · April 21, 2025
Alumis and ACELYRIN Announce Amended Merger Agreement
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis
By ACELYRIN, INC. · Via GlobeNewswire · April 21, 2025
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice (the “Notice”), dated April 15, 2025, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common shares had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”).
By Affimed N.V. · Via GlobeNewswire · April 21, 2025
Karviva Introduces Energy Juice Line Featuring Green Coffee Beans Designed for Wellness and Vitality
Saint Louis, Missouri, United States, 21st Apr 2025 – Karviva Beverages, renowned for its innovative and health-conscious approach to functional beverages, proudly introduces its latest creation: Karviva Energy Juice. This line of this clean energy drinks features two exciting flavors, Hibiscus Pomegranate and Mango Passion Fruit, designed to deliver sustained energy, mental wellness, and physical vitality.
Via Binary News Network · April 21, 2025
AIA Group Digital Transformation Strategy Profile 2025 - Accelerators, Incubators and Innovation Programs - ResearchAndMarkets.com
The "Enterprise Tech Ecosystem Series: AIA Group 2025" company profile has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · April 21, 2025
Tamboran Announce Resignation of Non-Executive Director
Tamboran Resources Corporation (NYSE: TBN, ASX: TBN) advises that Ms. Stephanie Reed has resigned as a Non-Executive Director of Tamboran’s Board of Directors to focus on other business interests.
By Tamboran Resources Corporation · Via Business Wire · April 21, 2025
New York Times Exposé Vindicates CCHR: ADHD Isn’t Biological, Says Watchdog
LOS ANGELES, Calif., April 21, 2025 (SEND2PRESS NEWSWIRE) -- A recent exposé in The New York Times Magazine will send shockwaves through the psychiatric community, affirming what the Citizens Commission on Human Rights International (CCHR) has warned for decades: there is no medical proof that Attention Deficit Hyperactivity Disorder (ADHD) is a biological disorder. Yet, over 3.4 million American children are labeled with ADHD and prescribed powerful, mind-altering stimulants. - News from Citizens Commission on Human Rights, issued by Send2Press Newswire
Via Send2Press · April 21, 2025
NESR Begins Construction of 180,000m(2) Facility at King Salman Energy Park (SPARK)
The state-of-the-art facility will be a key asset in Saudi Arabia's energy sector, offering advanced oilfield services and creating jobs opportunities
Via ACCESS Newswire · April 21, 2025
Investar Holding Corporation Announces 2025 First Quarter Results
BATON ROUGE, LA / ACCESS Newswire / April 21, 2025 / Investar Holding Corporation ("Investar") (NASDAQ:ISTR), the holding company for Investar Bank, National Association (the "Bank"), today announced financial results for the quarter ended March 31, 2025. Investar reported net income of $6.3 million, or $0.63 per diluted common share, for the first quarter of 2025, compared to net income of $6.1 million, or $0.61 per diluted common share, for the quarter ended December 31, 2024, and net income of $4.7 million, or $0.48 per diluted common share, for the quarter ended March 31, 2024.
Via ACCESS Newswire · April 21, 2025
Nepra Foods Proudly Announces Quotation On The OTCQB
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA), OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
Via ACCESS Newswire · April 21, 2025